Takeda Pharmaceutical Co Ltd - Company Profile
Powered by 
All the data and insights you need on Takeda Pharmaceutical Co Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Takeda Pharmaceutical Co Ltd Strategy Report
- Understand Takeda Pharmaceutical Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Business Description
Takeda Pharmaceutical Co Ltd (Takeda) develops, manufactures, sells, markets, imports and exports ethical pharmaceutical drugs for various conditions with special focus on neuroscience, rare diseases, gastrointestinal, plasma-derived therapies and oncology. Takeda markets in-house drugs in several countries across the world. It also develops vaccines for addressing critical public health threats using novel development platforms and more than 200 active collaborations with leading partners in their fields of research.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
The company’s R&D activities focus on therapeutic areas such as oncology, rare genetics & hematology, neuroscience and gastrointestinal and inflammation. It also has targeted R&D investments in plasma-derived therapies and vaccines. The company’s Investigator-Initiated Research (IIR) program facilitates innovative clinical and basic science studies that meet major medical and scientific queries related to its compounds and therapeutic areas of interest. Takeda has partnership with academic institutions, small biotech and large pharmaceutical companies. The company has more than 200 active partnerships worldwide. In FY2023, the company spent JPY633,325 million on its R&D activities, which grew 20.4% YoY, and as a percentage of revenue, stood at 15.7%. The company operates R&D facilities in Vienna, Austria; San Diego, California, and Cambridge, Massachusetts, the US; and Shonan, Japan.
Product Categories
Overview
Offer therapies for patients with inflammatory bowel disease, acid-related diseases, motility disorders and liver diseases. - Major products include Entyvio for moderate to severe ulcerative colitis; Dexilant for gastroesophageal reflux disease; Pantoprazole and Takecab-F for gastroesophageal reflux disease; and Amitiza for opioid-induced constipation, chronic idiopathic constipation and women with irritable bowel syndrome with constipation.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Offers products for patients with neurological diseases, including major depressive disorder, attention-deficit hyperactivity disorder and binge eating disorder. - Major products include Trintellix, an antidepressant used for the treatment of major depressive disorder in adults; Vyvanse, a stimulant medication used for the treatment of attention deficit hyperactivity disorder (ADHD); and Adderall XR for ADHD.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Provides medicines to patients with cancer across the world. - Major products include Ninlaro for multiple myeloma; Velcade for multiple myeloma and mantle cell lymphoma; Alunbrig for non-small cell lung cancer; and Iclusig for chronic myeloid leukemia.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Offers plasma derived therapies for immune deficiency diseases. - Major products include Albumin used for hypovolemia and hypoalbuminemia, and Immunoglobulin for primary immunodeficiency and multifocal motor neuropathy.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Offers a broad portfolio of products for hemophilia and hereditary bleeding disorders. - Major products include Advate and Adynovate for the treatment of hemophilia A; and FEIBA for patients with hemophilia A and B.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Geographical Segments
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward